The project, titled Liver Immunocompetent Volumetric Engineering (LIVE), aims to address the shortage of donor organs by ...

Unlike traditional transplant approaches, the goal is not to permanently replace a failing liver, but to create a temporary, ...

BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...

Intermountain Medical Center participated in a trial of the first bioengineered external liver, designed to help acute liver failure patients or are not eligible for or are waiting for a transplant a ...

(RTTNews) - Trestle Biotherapeutics, Inc. has partnered with Humacyte, Inc. (HUMA) to explore synergies in bioengineering vascularized organs for transplantation. Trestle Bio, a preclinical-stage ...

A phase 1 study of miroliverELAP for the treatment of acute liver failure is currently underway;1 first patient in the study underwent the procedure at Intermountain Medical Center in Murray, Utah ...

Bioengineered organs are no longer just structural substitutes. A new review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) ...

BROOKLYN, N.Y., April 2, 2025 /PRNewswire/ -- Xylyx Bio, Inc., a regenerative medicine company, announced that it has received $1,000,000 from the Richard M. Bartlett Jr. Memorial Foundation and ...

SAN DIEGO--(BUSINESS WIRE)--Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing ...

A US research team is developing a functional 3D bioprinted liver. The project, titled Liver Immunocompetent Volumetric ...